Skip to main content
OpenTrials

Clinical trial condition

Hematologic Malignancies

Explore clinical trials studying Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

136 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Malignancies trial results

Recruiting

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

NCT06823167

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations
  • City Of Hope Duarte, California, United States
  • University of California Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale University Medical Center New Haven, Connecticut, United States
View all 24 locations
View Trial Details
Recruiting

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

NCT06665100

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +4 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

NCT07359859

Conditions
Graft vs Host Disease, Hematologic Diseases, Hematologic Malignancies, +5 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

NCT01351545

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Anemia, +43 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Mayo Clinic Arizona (adults) Phoenix, Arizona, United States
View all 142 locations
View Trial Details
Recruiting

IVIG for Infection Prevention After CAR-T-Cell Therapy

NCT05952804

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View Trial Details

Related conditions